GSE147876 GSE147877 enzalutamide MR42D 2 v 9 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE147876_GSE147877_enzalutamide_MR42D_2_v_9_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE147876_GSE147877_enzalutamide_MR42D_2_v_9_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE147876_GSE147877_enzalutamide_MR42D_2_v_9_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE147876_GSE147877_enzalutamide_MR42D_2_v_9_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

acetylserotonin O-methyltransferase like

Gene

synergin gamma

Gene

long intergenic non-protein coding RNA 665

Gene

protein kinase Y-linked (pseudogene)

Gene

taxilin gamma Y-linked (pseudogene)

Gene

HLA complex group 18

Gene

Morf4 family associated protein 1 like 2

Gene

H2B clustered histone 20, pseudogene

Gene

H3 clustered histone 10

Gene

CD27 antisense RNA 1

  • Gene

    acetylserotonin O-methyltransferase like



  • Gene

    long intergenic non-protein coding RNA 665


  • Gene

    protein kinase Y-linked (pseudogene)


  • Gene

    taxilin gamma Y-linked (pseudogene)


  • Gene

    HLA complex group 18


  • Gene

    Morf4 family associated protein 1 like 2


  • Gene

    H2B clustered histone 20, pseudogene


  • Gene

    H3 clustered histone 10


  • Gene

    CD27 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.